More than 15 per cent of the revenues of top 10 pharma companies in India came from exports.


In the US generic market, 30 per cent of the drugs were sourced from India. "The size of Generic market in the regulated markets is expected to be around 60 billion USD in the next 2-3 years. Indian companies will be working to grab a good share in this," said Priolkar.


http://www.chennaionline.com/colnews/newsi...RYNAME=Business